However, in opposition to ANGPTL-3, ANGPTL-4 levels peaked in the advanced fibrosis group, with a value of 102.8 ng/mL, and remained relatively high in the cirrhosis and HCC groups. The gene discussed is ANGPTL4; the disease is hepatocellular carcinoma.